Zdrowie i gospodarka · 17/09/2018
FDA Renews Oncologic Drugs Advisory Committee for 2 Years
The FDA Commissioner has renewed the Oncologic Drugs Advisory Committee for an additional 2 years, extending its charter until September 1, 2020, in the public interest.
Source: Federal Register — Food and Drug AdministrationOpen original release →